Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wade H Berrettini

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Psychiatry (Edgmont (Pa. : Township))|January 4, 2011
Nicotine dependenceWade H Berrettini
Dialogues in Clinical Neuroscience|November 3, 2005
Genetic bases for endophenotypes in psychiatric disordersWade H Berrettini
Psychiatry (Edgmont (Pa. : Township))|December 2, 2010
Promising pharmacotherapy on the horizon for nicotine dependenceWade H Berrettini
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2017
Failure to Replicate an Association of a LINE-1 Element in ERI1 Exoribonuclease Family Member 3 (ERI3) with SchizophreniaGlenn A Doyle, Wade H Berrettini
Psychiatric Genetics|November 30, 2005
Lack of association between variations in the melanocortin 5 receptor gene and bipolar disorderFalk W Lohoff, Wade H Berrettini
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2015
Somatic DNA Variation in Brain as a Source of Risk for CNS DiseasesGlenn A Doyle, Wade H Berrettini
The American Journal of Psychiatry|August 2, 2005
Pharmacotherapy and pharmacogenetics of nicotine dependenceWade H Berrettini, Caryn E Lerman
Pharmacology, Biochemistry, and Behavior|November 9, 2013
Pharmacogenetics of OPRM1Richard C Crist, Wade H Berrettini
Addiction Biology|September 12, 2006
Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexoneDavid W Oslin, Wade H Berrettini, Charles P O'Brien
CNS Drugs|April 7, 2018
Pharmacogenetics of Opioid Use Disorder TreatmentRichard C Crist, Toni-Kim Clarke, Wade H Berrettini
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Psychiatry (Edgmont (Pa. : Township))|January 4, 2011
Nicotine dependenceWade H Berrettini
Dialogues in Clinical Neuroscience|November 3, 2005
Genetic bases for endophenotypes in psychiatric disordersWade H Berrettini
Psychiatry (Edgmont (Pa. : Township))|December 2, 2010
Promising pharmacotherapy on the horizon for nicotine dependenceWade H Berrettini
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2017
Failure to Replicate an Association of a LINE-1 Element in ERI1 Exoribonuclease Family Member 3 (ERI3) with SchizophreniaGlenn A Doyle, Wade H Berrettini
Psychiatric Genetics|November 30, 2005
Lack of association between variations in the melanocortin 5 receptor gene and bipolar disorderFalk W Lohoff, Wade H Berrettini
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2015
Somatic DNA Variation in Brain as a Source of Risk for CNS DiseasesGlenn A Doyle, Wade H Berrettini
The American Journal of Psychiatry|August 2, 2005
Pharmacotherapy and pharmacogenetics of nicotine dependenceWade H Berrettini, Caryn E Lerman
Pharmacology, Biochemistry, and Behavior|November 9, 2013
Pharmacogenetics of OPRM1Richard C Crist, Wade H Berrettini
Addiction Biology|September 12, 2006
Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexoneDavid W Oslin, Wade H Berrettini, Charles P O'Brien
CNS Drugs|April 7, 2018
Pharmacogenetics of Opioid Use Disorder TreatmentRichard C Crist, Toni-Kim Clarke, Wade H Berrettini
Pageof 18